Ultragenyx Pharmaceutical | Eiendeler



Assets Endring Dato
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Kyowa Hakko Kirin JPY 1.07T 25.4B 2024-12
MacroGenics USD 264.49M 63.36M 2024-09
Moderna USD 14.14B 1.66B 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Ultragenyx Pharmaceutical Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.